Wolverine Trading’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-100,000
| Closed | -$8.53M | – | 5750 |
|
|
2020
Q3 | $8.53M | Buy |
100,000
+200
| +0.2% | +$10.1K | 0.02% | 593 |
|
|
2020
Q2 | $3.42M | Buy |
99,800
+55,600
| +126% | +$1.63M | 0.01% | 1045 |
|
|
2020
Q1 | $608K | Sell |
44,200
-10,000
| -18% | -$168K | ﹤0.01% | 2449 |
|
|
2019
Q4 | $1.15M | Buy |
54,200
+11,500
| +27% | +$203K | ﹤0.01% | 2274 |
|
|
2019
Q3 | $611K | Sell |
42,700
-26,700
| -38% | -$392K | ﹤0.01% | 2426 |
|
|
2019
Q2 | $963K | Buy |
69,400
+14,000
| +25% | +$211K | ﹤0.01% | 2075 |
|
|
2019
Q1 | $1.06M | Sell |
55,400
-24,200
| -30% | -$390K | ﹤0.01% | 2016 |
|
|
2018
Q4 | $1.19M | Sell |
79,600
-36,200
| -31% | -$719K | ﹤0.01% | 1824 |
|
|
2018
Q3 | $2.41M | Buy |
115,800
+63,000
| +119% | +$1.49M | 0.01% | 1508 |
|
|
2018
Q2 | $771K | Hold |
52,800
| – | – | ﹤0.01% | 2546 |
|
|
2018
Q1 | $771K | Buy |
+52,800
| New | +$863K | ﹤0.01% | 2546 |
|
|
2016
Q4 | – | Sell |
-80,400
| Closed | -$257K | – | 5453 |
|
|
2016
Q3 | $257K | Sell |
80,400
-26,700
| -25% | -$74.7K | ﹤0.01% | 3457 |
|
|
2016
Q2 | $241K | Buy |
+107,100
| New | +$358K | ﹤0.01% | 3056 |
|
Wolverine Trading's IMMU Position: Q3 2020 in Review
Wolverine Trading sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 18,973 shares — an estimated $959K sold.
Wolverine Trading first reported a position in IMMU in Q2 2016 and held it in 10 quarters. The position peaked at $2.14M in Q3 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.
- Wolverine Trading reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
- Wolverine Trading sold 18,973 Immunomedics Inc shares in Q3 2020, an estimated $959K.
- Wolverine Trading first reported a position in Immunomedics Inc in Q2 2016 and held it in 10 quarters.
- Wolverine Trading's Immunomedics Inc position peaked at $2.14M in Q3 2018.
- 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.
Based on Wolverine Trading's 13F filing for Q3 2020, filed 13 Nov 2020.